Apart from compromising the targetability of melanoma cells by antigen-shedding, soluble CSPG4 might act as a decoy through blocking the CSPG4-binding site of circulating CSPG4-CAR-T cells, which could prevent the recognition of bona fide melanoma cells. This evidence concerns the gene CSPG4 and melanoma.